Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
7	7	Search

2025	RFX5 promotes the progression of triple-negative breast cancer through transcriptional activation of JAG1 Human Cell Chenhao Li, Xin Wang, Dongliang Shi, Meng Yang, Wenhua Yang, Liang Chen
2025	Knockdown of IER3 Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells Biomedicines Yuqing Han, Hongyang Ma, Zhihui Tang, Chanyuan Jin
2025	Structural basis of nucleosome binding and destabilization by the extended DNA binding domain of RFX5 Nucleic Acids Research Wanqiang Xue, Yaoyao Han, Ying Tian, Junzheng Wang, Zhiyuan Xie, Xin Zheng, Xue Yue, Siqi Dong, Huimin Li, Zhen Luo, Siqiu Zhang, Ying Yang, Zhe Zou, Wei Li, Nana Ma, Fangjie Zhu, Chunlai Chen, Yimeng Yin, Yixiao Zhang, Ke Xu
2024	Predictive value of immediate early response 5 like (IER5L) in the prognosis and immune checkpoint blockade therapy of non-small cell lung cancer patients Pathology - Research and Practice Nana Wang, Xiaofeng Tan, Shuming Cao, Meirong Liu
2023	Explore the impact of hypoxia-related genes (HRGs) in Cutaneous melanoma BMC Medical Genomics Guolin Ke, Nan Cheng, Huiya Sun, Xiumei Meng, Lei Xu
2023	Identify GADD45G as a potential target of 4-methoxydalbergione in treatment of liver cancer: bioinformatics analysis and in vivo experiment World Journal of Surgical Oncology Li-Ping Zeng, Yu-Qi Qin, Xiao-Min Lu, Zhen-Bo Feng, Xian-Lei Fang
2023	Construction and validation of a novel IGFBP3-related signature to predict prognosis and therapeutic decision making for Hepatocellular Carcinoma PeerJ Jianlin Chen, Wanzhen Zhuang, Yu Xia, Xiaoqing Yin, Mingshu Tu, Yi Zhang, Liangming Zhang, Hengbin Huang, Songgao Zhang, Lisheng You, Yi Huang